This is an open letter to all of the people behind the herpes cure scams out there. Please stop. You are preying on people who are desperate and possibly depressed because they have herpes. These are good people who have contracted a virus. They are scared, confused and looking for information. In most cases, they didn’t ask for this. They don’t need you trying to sell them your magic beans.
First, let us make one thing clear. At the time of this writing, there is no cure for herpes. Period. No herbal recipe, secret cocktail or magic potion will change that fact. We are a large community and have educated and warned others that your “Herpes cure” scams are just that. One big scam.
Besides being predatory and despicable, you are affecting the lives of others, What happens when they buy your scam product, think they are cured and spread it to their partner? That would be on you and you should be ashamed.
The minute you claim that you can cure herpes, we know it is a scam. We will even go one step further, “You are lying.” Plain and simple.
[click to continue…]
Project Wish, a clinical research site, out of University of Illinois at Chicago just let us know that they are launching a new herpes vaccine clinical trial and they are now enrolling volunteers . This is a PAID trial so you will be compensated for your time. Basically, they are looking for people aged 18-50 who are suffering from genital herpes. This study is being conducted to test the effectiveness of an investigational vaccine for HSV-2 in lowering the number of outbreaks.
The study will be closing enrollment soon so you will need to contact Gina Harden ASAP at 312-413-5897 or Ginaha@uic.edu.
Update: Enrollment ends on 3/31/2017
Here are the details of the study:
Study compensation ranges from $50-$100 depending on visit type. There will be a total of 12 visits.
Project WISH at UIC is now recruiting participants for the Vical HSV2 201 study!
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Safety and Efficacy of Herpes Simplex Virus, Type 2 (HSV-2) Therapeutic DNA Vaccine in Adults with Symptomatic Genital HSV-2 Infection. [click to continue…]
Pritelivir is a new herpes treatment in clinical trials that is already proving to be more effective than valacyclovir
Could pritelivir be the latest entry in the race for a herpes treatment? According to the Fred Hutchinson Cancer Research Center, the early clinical trials look very promising. Mary Engel just published another excellent article in the field of new advances in finding a treatment/cure for herpes. This time, she focuses on the German drug maker, AiCuris and their latest clinical trials on their new drug, pritelivir.
While still in the experimental stage, it is already proving to be more effective than valacyclovir (Valtrex) in its human trials according to the results published today.
The results of the phase 2, randomized, double-blind trial published today showed that when people with genital herpes took a daily oral dose of pritelivir, they reduced their rate of viral shedding by half compared to when they took valacyclovir. They also had fewer genital sores and less pain.
If pritelivir makes it to market, it would mean more options and competition. Right now, the only prescription options to treat herpes are valacyclovir (Valtrex), acyclovir (Zovirax) and famciclovir (Famvir) with each one having its own side effects. These drugs can be expensive and cost prohibitive, especially if you do not have insurance. More than a few have stuttered the words, “How…How much??” as they stood at the counter trying to pay for their first prescription. As new drugs hit the market, it will (Hopefully) drive the prices down. [click to continue…]
Drs. Martine Aubert and Keith Jerome showed for the first time in a living organism that DNA-cutting enzymes called targeted endonucleases can be used to disrupt latent herpes simplex virus. Photo by Robert Hood / Fred Hutch News Service
We received an email from Mary Engel, a couple of weeks ago, asking if there was any interest in a cure for herpes for her upcoming article for the Fred Hutch Cancer Research Center. Naturally, we knew the answer was an easy, “Yes!'”. Here is her article that has some really great information. We reprinted it with permission. At the bottom of the article is a link to Fred Hutch’s Facebook page so make sure to throw some likes their way. It sounds like they are doing some great work. The original article can be found here.
Can gene editing cure herpes?
Fred Hutch study shows ‘pathway to potential cure’ for herpes simplex and other latent viruses
Sept. 8, 2016
| By Mary Engel / Fred Hutch News Service
Scientists at Fred Hutchinson Cancer Research Center have used a gene-editing technique to attack the DNA of the herpes simplex virus in infected mice, a key step on the road to defeating an often-stigmatized virus that infects one in six people in the United States alone and for which there is no cure.
The study, published today in the journal JCI Insight, “lays out the pathway toward a potential cure for human herpesvirus infections,” said Dr. Keith Jerome, a Fred Hutch and University of Washington virologist and the paper’s senior author.
Researchers in Jerome’s lab deployed DNA-cutting enzymes called targeted endonucleases to damage the herpesvirus genome, inducing mutations that destroy the virus’ ability to replicate. The study is the first in a living organism — rather than a lab dish — to show that gene-editing tools can be delivered to the herpes simplex virus in its latent state or to a latent viral infection of any kind. Doing so is key to curing herpes because a latent infection can reactivate and seed new outbreaks. [click to continue…]
Central Kentucky Research Associates in Lexington, KY is now enrolling volunteers for a clinical research trial of an investigational therapeutic vaccine for HSV-2
If you live in or around Lexington, KY and want to take part of a clinical research trial for a HSV-2 vaccine, there are spots available! Greta BonDurant from Central Kentucky Research Associates just reached out to us to get volunteers for their new trial. Of, course, we are always happy to help.
Here is her email:
I am writing to let you know that Central Kentucky Research Associates in Lexington, KY is now enrolling volunteers for a clinical research trial of an investigational therapeutic vaccine for HSV-2.
We are looking for people between the ages of 18 and 50 who have had HSV-2 for at least 1 year and who have had between 4 and 9 recurrences over the past 12 months to participate. We wanted to reach out to the support groups in this area to make them aware of the study, so any help you can offer in terms of spreading the word about this important study to your members would be greatly appreciated!
If you have any questions or would like some more information, I can be reached at 859-264-8999 or at the email address provided.
Thank you in advance for your time!
We asked her for a website because these pages get a lot of traffic and didn’t want her phone to go crazy. She replied, quickly: [click to continue…]
We just opened a secret Facebook group! Facebook has become wildly popular for their groups and especially for people with herpes. There is an entire network of secret herpes Facebook groups already out there with 1000’s of members. Some focus on support while others are regional, by state and even event related.
Just to clarify, once you are a member it is totally up to you if you want to join our Facebook group. It was simply created as an option and the same rules of conduct of the site also apply in the group. If you are still interested, read on!
You may be asking yourself why we would ever open up our own group when we already have an awesome community. Just off the top of our heads, we came up with the four biggest ones.
Our Members – They asked for it and we delivered! We really appreciate our members and listen to their wishes. This gives them another line of communication with other members and access to other secret groups. Since Facebook is so easily accessible, it is much easier to check your account at work with worrying about the IT guy seeing that you visited HWerks. Many also prefer Facebook over the forums. That brings us to our next point…
[click to continue…]